Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.130
-0.210 (-6.29%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Nephros Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Nephros stock has a consensus rating of "Buy" and an average price target of $7.00. The average 1-year stock price forecast is 123.64% higher than the current stock price, while the lowest is $6.00 (+91.69%) and the highest is $8.00 (+155.59%).
Price Target: $7.00 (+123.64%)
Analyst Consensus: Buy
* Price targets were last updated on May 9, 2026.
Analyst Ratings
The average analyst rating for Nephros stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | May '25 | Aug '25 | Nov '25 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +155.59% | May 9, 2026 |
Financial Forecast
Revenue This Year
21.08M
from 18.79M
Increased by 12.21%
Revenue Next Year
23.13M
from 21.08M
Increased by 9.69%
EPS This Year
0.05
from 0.11
Decreased by -59.09%
EPS Next Year
0.10
from 0.05
Increased by 122.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 21.2M | |
| Avg | 21.1M | |
| Low | 21.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 12.6% | |
| Avg | 12.2% | |
| Low | 11.8% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | - | |
| Avg | 0.05 | |
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | |
| Avg | -59.1% | |
| Low | - |